Gender differences in Parkinson's disease: A clinical perspective
Corresponding Author
D. Georgiev
Department of Neurology, University Clinical Centre Ljubljana, Ljubljana, Slovenia
Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UK
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden
Correspondence
Dejan Georgiev, Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Emails: [email protected]; [email protected]
Search for more papers by this authorK. Hamberg
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden
Search for more papers by this authorM. Hariz
Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UK
Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
Search for more papers by this authorL. Forsgren
Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
Search for more papers by this authorG.-M. Hariz
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden
Search for more papers by this authorCorresponding Author
D. Georgiev
Department of Neurology, University Clinical Centre Ljubljana, Ljubljana, Slovenia
Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UK
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden
Correspondence
Dejan Georgiev, Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Emails: [email protected]; [email protected]
Search for more papers by this authorK. Hamberg
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden
Search for more papers by this authorM. Hariz
Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London, UK
Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
Search for more papers by this authorL. Forsgren
Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
Search for more papers by this authorG.-M. Hariz
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden
Search for more papers by this authorAbstract
Available data indicate that there are gender differences in many features of Parkinson's disease (PD). Precise identification of the gender differences is important to tailor treatment, predict outcomes, and meet other individual and social needs in women and men with PD. The aim of this study was to review the available clinical data on gender differences in PD. Original articles and meta-analyses published between 1990 and 2016 systematically exploring gender differences in PD were reviewed. There is slight male preponderance in incidence and prevalence of PD. PD starts earlier in men. Women tend to be more prone to develop tremor-dominant PD but are less rigid than men. Motor improvement after deep brain stimulation is equal in both sexes, but women tend to show better improvement in activities of daily living. Furthermore, women with PD show better results on tests for general cognitive abilities, outperform men in verbal cognitive tasks, show more pain symptoms, and score higher on depression scales. It seems, however, that the differences in cognition, mood, and pain perception are not disease specific as similar gender differences can be found in healthy subjects and in other neurological conditions. Despite PD being the most frequently studied movement disorder, studies investigating gender differences in PD are still scarce with most of the studies being cross-sectional. Good-quality, prospective, longitudinal studies analyzing gender differences in PD and comparing them to matched healthy controls are needed in order to properly address the issues of gender differences in PD.
REFERENCES
- 1Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009; 373: 2055-2066.
- 2Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H. Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol. 2005; 64: 623-628.
- 3Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006; 5: 235-245.
- 4Pavon JM, Whitson HE, Okun MS. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas. 2010; 65: 352-358.
- 5Young LJ, Pfaff DW. Sex differences in neurological and psychiatric disorders. Front Neuroendocrinol. 2014; 35: 253-254.
- 6Risberg G, Johansson EE, Hamberg K. A theoretical model for analysing gender bias in medicine. Int J Equity Health. 2009; 8: 28.
- 7Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Progressive supranuclear palsy: phenotypic sex differences in a clinical cohort. Mov Disord. 2006; 21: 689-692.
- 8Caslake R, Taylor K, Scott N, et al. Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study. Parkinsonism Relat Disord. 2014; 20: 834-839.
- 9Yamamoto T, Sakakibara R, Uchiyama T, et al. Time-dependent changes and gender differences in urinary dysfunction in patients with multiple system atrophy. Neurourol Urodyn. 2014; 33: 516-523.
- 10Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 2000; 55: 1358-1363.
- 11Alves G, Muller B, Herlofson K, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry. 2009; 80: 851-857.
- 12Linder J, Stenlund H, Forsgren L. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study. Mov Disord. 2010; 25: 341-348.
- 13Kovacs M, Makkos A, Aschermann Z, et al. Impact of sex on the nonmotor symptoms and the health-related quality of life in Parkinson's disease. Parkinsons Dis. 2016; 2016: 7951840.
- 14Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995; 142: 820-827.
- 15Wooten GF. Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry. 2004; 75: 637-639.
- 16Elbaz A, Bower JH, Maraganore DM, et al. Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol. 2002; 55: 25-31.
- 17de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004; 63: 1240-1244.
- 18Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003; 157: 1015-1022.
- 19Martinez-Rumayor A, Arrieta O, Sotelo J, Garcia E. Female gender but not cigarette smoking delays the onset of Parkinson's disease. Clin Neurol Neurosurg. 2009; 111: 738-741.
- 20Haaxma CA, Bloem BR, Borm GF, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007; 78: 819-824.
- 21Augustine EF, Perez A, Dhall R, et al. Sex differences in clinical features of early. Treated Parkinson's disease. PLoS ONE. 2015; 10: e0133002.
- 22Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson's disease phenotype. J Neurol. 2005; 252: 1201-1205.
- 23Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM. Gender differences in Parkinson's disease symptom profile. Acta Neurol Scand. 2000; 102: 37-43.
- 24Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Risk factors for Parkinson's disease may differ in men and women: an exploratory study. Horm Behav. 2013; 63: 308-314.
- 25Gao X, O'Reilly EJ, Schwarzschild MA, Ascherio A. Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology. 2016; 86: 520-526.
- 26Cilia R, Siri C, Rusconi D, et al. LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population. Parkinsonism Relat Disord. 2014; 20: 911-914.
- 27Gan-Or Z, Leblond CS, Mallett V, Orr-Urtreger A, Dion PA, Rouleau GA. LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis Parkinsonism Relat Disord. 2015; 21: 778-782.
- 28Saunders-Pullman R, Stanley K, San Luciano M, et al. Gender differences in the risk of familial parkinsonism: beyond LRRK2? Neurosci Lett. 2011; 496: 125-128.
- 29Kelada SN, Costa-Mallen P, Costa LG, et al. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. NeuroToxicol. 2002; 23: 515-519.
- 30Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, et al. Effects of gender on nigral gene expression and Parkinson disease. Neurobiol Dis. 2007; 26: 606-614.
- 31Trabzuni D, Ramasamy A, Imran S, et al. Widespread sex differences in gene expression and splicing in the adult human brain. Nat Commun 2013; 4: 2771.
- 32Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC. Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS ONE. 2010; 5: e8856.
- 33Nishioka K, Kefi M, Jasinska-Myga B, et al. A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010; 81: 391-395.
- 34Chahine LM, Qiang J, Ashbridge E, et al. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. JAMA Neurol. 2013; 70: 852-858.
- 35Shulman LM. Gender differences in Parkinson's disease. Gend Med. 2007; 4: 8-18.
- 36Miller IN, Cronin-Golomb A. Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord. 2010; 25: 2695-2703.
- 37Nitkowska M, Czyzyk M, Friedman A. Reproductive life characteristics in females affected with Parkinson's disease and in healthy control subjects – a comparative study on Polish population. Neurol Neurochir Pol. 2014; 48: 322-327.
- 38Nitkowska M, Tomasiuk R, Czyzyk M, Friedman A. Prolactin and sex hormones levels in males with Parkinson's disease. Acta Neurol Scand. 2015; 131: 411-416.
- 39Benedetti MD, Maraganore DM, Bower JH, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord. 2001; 16: 830-837.
- 40Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007; 17: 643-653.
- 41Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol Clin. 1996; 14: 317-335.
- 42Bergareche A, De La Puente E, Lopez de Munain A, et al. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain. J Neurol. 2004; 251: 340-345.
- 43de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 10-15.
- 44Nicoletti A, Sofia V, Bartoloni A, et al. Prevalence of Parkinson's disease: a door-to-door survey in rural Bolivia. Parkinsonism Relat Disord. 2003; 10: 19-21.
- 45Solla P, Cannas A, Ibba FC, et al. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease. J Neurol Sci. 2012; 323: 33-39.
- 46Kotagal V, Albin RL, Muller ML, Koeppe RA, Frey KA, Bohnen NI. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. J Neural Transm (Vienna). 2013; 120: 1421-1424.
- 47Lee JJ, Ham JH, Lee PH, Sohn YH. Gender differences in age-related striatal dopamine depletion in Parkinson's disease. J Mov Disord. 2015; 8: 130-135.
- 48Laakso A, Vilkman H, Bergman J, et al. Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry. 2002; 52: 759-763.
- 49Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014; 20: 99-105.
- 50Picillo M, Erro R, Amboni M, et al. Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients. Parkinsonism Relat Disord. 2014; 20: 850-854.
- 51Accolla E, Caputo E, Cogiamanian F, et al. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation. Mov Disord. 2007; 22: 1150-1156.
- 52Umeh CC, Perez A, Augustine EF, et al. No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada – baseline findings of a multicenter trial. PLoS ONE. 2014; 9: e112287.
- 53Gao L, Nie K, Tang H, et al. Sex differences in cognition among Chinese people with Parkinson's disease. J Clin Neurosci. 2015; 22: 488-492.
- 54Hassin-Baer S, Molchadski I, Cohen OS, et al. Gender effect on time to levodopa-induced dyskinesias. J Neurol. 2011; 258: 2048-2053.
- 55Colombo D, Abbruzzese G, Antonini A, et al. The “gender factor” in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study. ScientificWorldJournal. 2015; 2015: 787451.
- 56Kumagai T, Nagayama H, Ota T, Nishiyama Y, Mishina M, Ueda M. Sex differences in the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin Neuropharmacol. 2014; 37: 173-176.
- 57Kompoliti K, Adler CH, Raman R, et al. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002; 58: 1418-1422.
- 58Olanow CW, Kieburtz K, Rascol O, et al. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord. 2013; 28: 1064-1071.
- 59Picillo M, Palladino R, Moccia M, et al. Gender and non motor fluctuations in Parkinson's disease: a prospective study. Parkinsonism Relat Disord. 2016; 27: 89-92.
- 60Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015; 30: 1591-1601.
- 61Kim SR, So HY, Choi E, Kang JH, Kim HY, Chung SJ. Influencing effect of non-motor symptom clusters on quality of life in Parkinson's disease. J Neurol Sci. 2014; 347: 310-315.
- 62Heller J, Dogan I, Schulz JB, Reetz K. Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease? Aging Dis. 2014; 5: 63-75.
- 63Liu R, Umbach DM, Peddada SD, et al. Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease. Neurology. 2015; 84: 2107-2115.
- 64Carey JR, Deskin KA, Josephson KT, Wichmann RL. Sex differences in tracking performance in patients with Parkinson's disease. Arch Phys Med Rehabil. 2002; 83: 972-977.
- 65Munro CA, Winicki JM, Schretlen DJ, et al. Sex differences in cognition in healthy elderly individuals. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2012; 19: 759-768.
- 66Sundermann EE, Biegon A, Rubin LH, et al. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016; 86: 1368-1376.
- 67Sundermann EE, Maki PM, Rubin LH, et al. Female advantage in verbal memory: evidence of sex-specific cognitive reserve. Neurology. 2016; 87: 1916-1924.
- 68Hamberg K. Biology, gender and behaviour. A critical discussion of the biological models used for explaining cognitive and behavioural gender differences. In: JW Lee, ed. Psychology of Gender Identity. New York, NY: Noca Science Publisher, Inc; 2005: 127-144.
- 69Foltynie T, Lewis SG, Goldberg TE, et al. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol. 2005; 252: 833-838.
- 70Caranci G, Piscopo P, Rivabene R, et al. Gender differences in Parkinson's disease: focus on plasma alpha-synuclein. J Neural Transm (Vienna). 2013; 120: 1209-1215.
- 71Guo X, Song W, Chen K, et al. Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease–a study from Southwest China. Parkinsonism Relat Disord. 2013; 19: 961-965.
- 72Martinez-Martin P, Falup Pecurariu C, Odin P, et al. Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol. 2012; 259: 1639-1647.
- 73Song Y, Gu Z, An J, Chan P, Chinese Parkinson Study G. Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson's disease. Neurol Sci 2014; 35: 1991-1996.
- 74Picillo M, Amboni M, Erro R, et al. Gender differences in non-motor symptoms in early, drug naive Parkinson's disease. J Neurol. 2013; 260: 2849-2855.
- 75van der Hoek TC, Bus BA, Matui P, van der Marck MA, Esselink RA, Tendolkar I. Prevalence of depression in Parkinson's disease: effects of disease stage, motor subtype and gender. J Neurol Sci. 2011; 310: 220-224.
- 76Hankin BL, Abramson LY. Development of gender differences in depression: an elaborated cognitive vulnerability-transactional stress theory. Psychol Bull. 2001; 127: 773-796.
- 77Nolen-Hoeksema S, Larson J, Grayson C. Explaining the gender difference in depressive symptoms. J Pers Soc Psychol. 1999; 77: 1061-1072.
- 78Meyer A, Zimmermann R, Gschwandtner U, et al. Apathy in Parkinson's disease is related to executive function, gender and age but not to depression. Front Aging Neurosci. 2014; 6: 350.
- 79Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med. 2005; 2: 137-145.
- 80Mylius V, Kunz M, Schepelmann K, Lautenbacher S. Sex differences in nociceptive withdrawal reflex and pain perception. Somatosens Mot Res. 2005; 22: 207-211.
- 81Bjørnara KA, Dietrichs E, Toft M. REM sleep behavior disorder in Parkinson's disease–is there a gender difference? Parkinsonism Relat Disord. 2013; 19: 120-122.
- 82Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009; 72: 1296-1300.
- 83Walker R, Davidson M, Gray W. Gender differences in 1-year survival rates after weight loss in people with idiopathic Parkinson's disease. Int J Palliat Nurs. 2012; 18: 35-39.
10.12968/ijpn.2012.18.1.35 Google Scholar
- 84Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010; 67: 589-595.
- 85Joutsa J, Martikainen K, Vahlberg T, Kaasinen V. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2012; 18: 1079-1083.
- 86Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron. 2009; 61: 502-510.
- 87Lubomski M, Louise Rushworth R, Lee W, Bertram KL, Williams DR. Sex differences in Parkinson's disease. J Clin Neurosci. 2014; 21: 1503-1506.
- 88Hariz GM, Limousin P, Zrinzo L, et al. Gender differences in quality of life following subthalamic stimulation for Parkinson's disease. Acta Neurol Scand. 2013; 128: 281-285.
- 89Hariz GM, Lindberg M, Hariz MI, Bergenheim AT. Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery. Acta Neurol Scand. 2003; 108: 28-37.
- 90Moore O, Kreitler S, Ehrenfeld M, Giladi N. Quality of life and gender identity in Parkinson's disease. J Neural Transm. 2005; 112: 1511-1522.
- 91Hariz GM, Nakajima T, Limousin P, et al. Gender distribution of patients with Parkinson's disease treated with subthalamic deep brain stimulation; a review of the 2000-2009 literature. Parkinsonism Relat Disord. 2011; 17: 146-149.
- 92Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007; 106: 621-625.
- 93Chiou SM. Sex-related prognostic predictors for Parkinson disease undergoing subthalamic stimulation. World Neurosurg. 2015; 84: 906-912.
- 94Hamberg K, Hariz GM. The decision-making process leading to deep brain stimulation in men and women with parkinson's disease – an interview study. BMC Neurol. 2014; 14: 89.
- 95Hariz GM, Hariz MI. Gender distribution in surgery for Parkinson's disease. Parkinsonism Relat Disord. 2000; 6: 155-157.
- 96McCarthy MM, Arnold AP, Ball GF, Blaustein JD, De Vries GJ. Sex differences in the brain: the not so inconvenient truth. J Neurosci. 2012; 32: 2241-2247.
- 97Marceglia S, Mrakic-Sposta S, Foffani G, et al. Gender-related differences in the human subthalamic area: a local field potential study. Eur J Neuorsci. 2006; 24: 3213-3222.
- 98Hamberg K. Gender bias in medicine. Women's Health. 2008; 4: 237-243.